IA
AMPH icon

IFP Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

IFP Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.37K Sell
70
-900
-93% -$22K ﹤0.01% 4087
2025
Q4 		$26K Sell
970
-600
-38% -$15.5K ﹤0.01% 2590
2025
Q3 		$41.8K Sell
1,570
-465
-23% -$12K ﹤0.01% 2167
2025
Q2 		$51.9K Buy
2,035
+877
+76% +$21.8K ﹤0.01% 2026
2025
Q1 		$33.7K Buy
+1,158
New +$37K ﹤0.01% 2069
2024
Q4 		– Hold
0
– – – 4134
2023
Q1 		– Sell
-18
Closed -$3K – 3388
2022
Q4 		$3K Sell
18
-75
-81% -$2.18K ﹤0.01% 3971
2022
Q3 		$6K Sell
93
-86
-48% -$2.81K ﹤0.01% 3910
2022
Q2 		$7K Hold
179
– – ﹤0.01% 3577
2022
Q1 		$7K Buy
+179
New +$5.08K ﹤0.01% 3577
2019
Q1 		– Sell
-1,410
Closed -$28K – 2388
2018
Q4 		$28K Hold
1,410
– – ﹤0.01% 1934
2018
Q3 		$27K Buy
1,410
+100
+8% +$1.78K ﹤0.01% 2273
2018
Q2 		$20K Buy
1,310
+1,000
+323% +$17.5K ﹤0.01% 2458
2018
Q1 		$6K Hold
310
– – ﹤0.01% 3046
2017
Q4 		$6K Sell
310
-1,250
-80% -$23.3K ﹤0.01% 3092
2017
Q3 		$28K Buy
+1,560
New +$25.7K ﹤0.01% 2374

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

IFP Advisors's AMPH Position: Q1 2026 in Review

IFP Advisors reduced its Amphastar Pharmaceuticals (AMPH) stake by 93% in Q1 2026, selling an estimated $22K and leaving 70 shares worth $1.37K. The position accounts for ﹤0.01% of the portfolio, ranked #4087.

IFP Advisors first reported a position in AMPH in Q3 2017 and has held it in 15 quarters since. The position peaked at $51.9K in Q2 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • IFP Advisors held 70 shares of Amphastar Pharmaceuticals worth $1.37K as of Q1 2026.
  • IFP Advisors sold 900 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $22K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #4087 holding.
  • IFP Advisors first reported a position in Amphastar Pharmaceuticals in Q3 2017 and has held it in 15 quarters since.
  • IFP Advisors's Amphastar Pharmaceuticals position peaked at $51.9K in Q2 2025.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.